NewsBenzingaVera Therapeutics To Present Multiple Presentations At American Society Of Nephrology Kidney Week 2026 For Its Final Efficacy Analysis Of ORIGIN 3 Study Of TRUTAKNA In IgA Nephropathy Vera Therapeutics To Present Multiple Presentations At American Society Of Nephrology Kidney Week 2026 For Its Final Efficacy Analysis Of ORIGIN 3 Study Of TRUTAKNA In IgA Nephropathy Benzinga 2026.10.02 13:28 (GMT+0) Open on Benzinga Other news UBS Maintains Buy on United Airlines Holdings, Lowers Price Target to $139 Palantir Technologies Stock Is Falling Friday: What's Going On? UBS Maintains Buy on Charles Schwab, Lowers Price Target to $109 UBS Maintains Neutral on Public Storage, Lowers Price Target to $294 UBS Maintains Neutral on ManpowerGroup, Lowers Price Target to $48 Keefe, Bruyette & Woods Maintains Market Perform on PNC Financial Services Gr, Lowers Price Target to $250
Keefe, Bruyette & Woods Maintains Market Perform on PNC Financial Services Gr, Lowers Price Target to $250
